Efficacy and safety of oral Morphine versus oral Prolonged-Release Oxycodone/Naloxone in opioid-naive cancer patients: a propensity analysis

被引：0
|
作者：
Greco, M. T. [1 ]
Roberto, A. [2 ]
Legramandi, L. [2 ]
Galli, F. [2 ]
Corli, O. [2 ]
机构：
[1] Univ Milan, Unita Stat Med & Biometria GA Maccacaro, Dipartimento Sci Clin & Comunia, Milan, Italy
[2] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Oncol, Lab Metodol Ric Clin, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw344.1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
R01
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial
    Lee, Kyung-Hee
    Kim, Tae Won
    Kang, Jung-Hun
    Kim, Jin-Soo
    Ahn, Jin-Seok
    Kim, Sun-Young
    Yun, Hwan-Jung
    Eum, Young-Jun
    Koh, Sung Ae
    Kim, Min Kyoung
    Hong, Yong Sang
    Kim, Jeong Eun
    Lee, Gyeong-Won
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [42] Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: An open-label trial
    Narabayashi, Masaru
    Saijo, Yasuo
    Takenoshita, Seiichi
    Chida, Masayuki
    Shimoyama, Naohito
    Miura, Takeshi
    Tani, Kazuhiko
    Nishimura, Kousuke
    Onozawa, Yusuke
    Hosokawa, Toyoshi
    Kamoto, Toshiyuki
    Tsushima, Tomoyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) : 296 - 304
  • [43] High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain
    Francesco Amato
    Silvia Ceniti
    Sergio Mameli
    Giovanni M. Pisanu
    Renato Vellucci
    Vincenzo Palmieri
    Leonardo Consoletti
    Dorotea Magaldi
    Paolo Notaro
    Claudio Marcassa
    Supportive Care in Cancer, 2017, 25 : 3051 - 3058
  • [44] High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain
    Amato, Francesco
    Ceniti, Silvia
    Mameli, Sergio
    Pisanu, Giovanni M.
    Vellucci, Renato
    Palmieri, Vincenzo
    Consoletti, Leonardo
    Magaldi, Dorotea
    Notaro, Paolo
    Marcassa, Claudio
    SUPPORTIVE CARE IN CANCER, 2017, 25 (10) : 3051 - 3058
  • [45] Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study
    Bantel, Carsten
    Tripathi, Shiva S.
    Molony, David
    Heffernan, Tony
    Oomman, Susmita
    Mehta, Vivek
    Dickerson, Sara
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 57 - 67
  • [46] Opioid-Induced Constipation Relief From Fixed-Ratio Combination Prolonged-Release Oxycodone/Naloxone Compared With Oxycodone and Morphine for Chronic Nonmalignant Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Huang, Lang
    Zhou, Jian-Guo
    Zhang, Yu
    Wang, Fei
    Wang, Yi
    Liu, Da-Hai
    Li, Xin-Juan
    Lv, Shui-Ping
    Jin, Su-Han
    Bai, Yu-Ju
    Ma, Hu
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (05) : 737 - +
  • [47] Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis
    Paridaens, Kristine
    Fullarton, John R.
    Travis, Simon P. L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1891 - 1900
  • [48] Pharmacokinetic and pharmacodynamic study of S-8117 (controlled-release oxycodone tablet) on opioid-naive patients with cancer-related pain
    Koizumi, W
    Tanabe, S
    Nagaba, S
    Saigenji, K
    Nonaka, M
    Yago, K
    EUROPEAN JOURNAL OF PAIN-LONDON, 2001, 5 : 133 - 134
  • [49] Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain
    Graziella Madeo
    Tommaso Schirinzi
    Silvia Natoli
    Mariangela Pierantozzi
    Alessandro Stefani
    Mario Dauri
    Antonio Pisani
    Journal of Neurology, 2015, 262 : 2164 - 2170
  • [50] Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
    Bruera, E
    Belzile, M
    Pituskin, E
    Fainsinger, R
    Darke, A
    Harsanyi, Z
    Babul, N
    Ford, I
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3222 - 3229
12345